Literature DB >> 15617052

Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations.

Afonso C Silva1, Jung Hee Lee, Ichio Aoki, Alan P Koretsky.   

Abstract

Manganese-enhanced MRI (MEMRI) is being increasingly used for MRI in animals due to the unique T1 contrast that is sensitive to a number of biological processes. Three specific uses of MEMRI have been demonstrated: to visualize activity in the brain and the heart; to trace neuronal specific connections in the brain; and to enhance the brain cytoarchitecture after a systemic dose. Based on an ever-growing number of applications, MEMRI is proving useful as a new molecular imaging method to visualize functional neural circuits and anatomy as well as function in the brain in vivo. Paramount to the successful application of MEMRI is the ability to deliver Mn2+ to the site of interest at an appropriate dose and in a time-efficient manner. A major drawback to the use of Mn2+ as a contrast agent is its cellular toxicity. Therefore, it is critical to use as low a dose as possible. In the present work the different approaches to MEMRI are reviewed from a practical standpoint. Emphasis is given to the experimental methodology of how to achieve significant, yet safe, amounts of Mn2+ to the target areas of interest. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15617052     DOI: 10.1002/nbm.945

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  161 in total

1.  Blast-induced tinnitus and hearing loss in rats: behavioral and imaging assays.

Authors:  Johnny C Mao; Edward Pace; Paige Pierozynski; Zhifeng Kou; Yimin Shen; Pamela VandeVord; E Mark Haacke; Xueguo Zhang; Jinsheng Zhang
Journal:  J Neurotrauma       Date:  2011-11-22       Impact factor: 5.269

2.  Manganese-enhanced magnetic resonance imaging (MEMRI).

Authors:  Cynthia A Massaad; Robia G Pautler
Journal:  Methods Mol Biol       Date:  2011

3.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

4.  Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI.

Authors:  Joseph J Gallagher; Xiaowei Zhang; Gregory J Ziomek; Russell E Jacobs; Elaine L Bearer
Journal:  Neuroimage       Date:  2012-02-10       Impact factor: 6.556

5.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

6.  New clues and new questions regarding leptin and brain metabolism.

Authors:  Mary C McKenna
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-05       Impact factor: 6.200

7.  Measurement of manganese content in various organs in rats with or without glucose stimulation.

Authors:  Mamoru Nagata; Toshio Kagawa; Daichi Koutou; Taro Matsushita; Youichi Yamazaki; Kenya Murase
Journal:  Radiol Phys Technol       Date:  2010-08-17

8.  Retinal ion regulation in a mouse model of diabetic retinopathy: natural history and the effect of Cu/Zn superoxide dismutase overexpression.

Authors:  Bruce A Berkowitz; Marius Gradianu; David Bissig; Timothy S Kern; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

9.  Manganese-enhanced MRI (MEMRI) via topical loading of Mn(2+) significantly impairs mouse visual acuity: a comparison with intravitreal injection.

Authors:  Tsen-Hsuan Lin; Chia-Wen Chiang; Kathryn Trinkaus; William M Spees; Peng Sun; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2014-01-16       Impact factor: 4.044

10.  Deletion in the N-terminal half of olfactomedin 1 modifies its interaction with synaptic proteins and causes brain dystrophy and abnormal behavior in mice.

Authors:  Naoki Nakaya; Afia Sultana; Jeeva Munasinghe; Aiwu Cheng; Mark P Mattson; Stanislav I Tomarev
Journal:  Exp Neurol       Date:  2013-10-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.